Zura Bio Limited

1489 W. Warm Springs Rd. #110

Henderson, NV 89014

September 16, 2024

 

VIA EDGAR

 

Division of Corporation Finance

Office of Technology

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

RE:	Zura Bio Limited
	Registration Statement on Form S-3
	File No. 333-281905

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Exchange Act of 1933, as amended, Zura Bio Limited (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on September 17, 2024, at 9:00 a.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Divakar Gupta, Sarah Sellers and Brandon Fenn of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

 

Once the Registration Statement has been declared effective, please orally confirm that event with Sarah Sellers of Cooley LLP, counsel to the Registrant, at (212) 479-6370, or in her absence, Brandon Fenn at (212) 479-6626.

 

	Very truly yours,
	ZURA BIO LIMITED
	By:	/s/ Verender Badial
	Name:	Verender Badial
	Title:	Chief Financial Officer

 

cc:	Kim Davis, Zura Bio Limited
	Divakar Gupta, Cooley LLP
	Sarah Sellers, Cooley LLP
	Brandon Fenn, Cooley LLP